ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Anlon Healthcare incorporated ANLON Healthcare Nigeria Limited, holding 90% stake. The subsidiary aims to expand pharmaceutical and healthcare operations across 16 West African countries.
Anlon Healthcare's AGM approved acquiring Apiqo Organics and Bizotic Lifescience stakes via share swap. The filing adds preferential issue pricing of ₹17.85 per share.
Anlon Healthcare responded to NSE/BSE surveillance queries stating no undisclosed information explains the price movement. The company attributes the move to market-driven factors.
Brickwork Ratings assigned BWR BBB/Stable to Anlon Healthcare's ₹23.60 Crore fund-based term loan. The rating reflects improved profitability and low leverage following the company's 2025 IPO.
Anlon Healthcare Limited held its 13th Annual General Meeting on September 05, 2025. Shareholders considered financial statements, director appointments, and a preferential issue of equity shares.
Anlon Healthcare Q1 FY27 results show strong top-line growth following the acquisition of Remember India Health Links, though EBITDA margins faced temporary pressure from surging raw material costs and consolidation expenses.
Anlon Healthcare is transitioning to an integrated pharma player via strategic acquisitions. Reported FY26 revenue of ₹171.97 Cr with a 27.74% EBITDA margin, focusing on backward integration and high-value APIs.
Anlon Healthcare Ltd reported revenue from operations of ₹87.6 Cr (+163.1% YoY) and net profit of ₹8.3 Cr (+137.1% YoY) for Q1 FY27.
Anlon Healthcare Ltd reported revenue from operations of ₹33.3 Cr (-11.9% YoY) and net profit of ₹3.5 Cr (-7.9% YoY) for Q1 FY26.
Anlon Healthcare Limited reported FY26 consolidated total income of ₹172.22 Cr, up 42.98% YoY. Strategy focuses on API expansion and CDMO scaling.
Anlon Healthcare reports strong FY26 growth with revenues reaching ₹171.97cr, up from ₹120.29cr in FY25. Strategy focuses on backward integration and expansion via Bizotic and Apiqo acquisitions.
Anlon Healthcare Ltd reported revenue from operations of ₹50.9 Cr (+4.1% YoY) and net profit of ₹11.1 Cr (-33.1% YoY) for Q4 FY26.